This is in agreement with the results from Rizzo et al., which showed that in early untreated RA patients, detectable levels of sHLA-G in plasma could be observed in all subjects, as compared to a minority (23%) of healthy controls, and that those levels increased upon anti-RA treatment in those patients [23]. Here, HLA-G is linked to rheumatoid arthritis.